查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球胰岛素给药设备市场研究报告 - 2023 年至 2030 年的行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1314756

全球胰岛素给药设备市场研究报告 - 2023 年至 2030 年的行业分析、规模、份额、增长、趋势和预测

Global Insulin Delivery Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

据预测，胰岛素给药设备市场的全球需求将从 2022 年的 201.2 亿美元增至 2030 年的近 447.3 亿美元，2023-2030 年的复合年增长率为 10.5%。在数量方面，2022 年的市场规模为 XX 千台，预计到 2030 年将达到 XX 千台，2023-2030 年的复合年增长率为 XX%。

胰岛素给药装置用于为确诊为糖尿病的患者注射胰岛素。胰岛素是一种激素，由胰腺分泌，可调节血糖水平。糖尿病患者的身体要么不能产生足够的胰岛素（1 型糖尿病），要么不能有效利用所产生的胰岛素（2 型糖尿病）。胰岛素治疗对控制糖尿病和维持最佳血糖控制至关重要。

市场动态：

随着越来越多的人被诊断出患有糖尿病并需要接受胰岛素治疗，全球糖尿病患病率的不断上升成为主要驱动因素。创新的胰岛素给药设备具有精确给药、更高的可用性、连接性和数据跟踪功能等特点，提高了便利性和治疗效果。由于胰岛素泵设计的改进、使用的简便性和更好的报销政策，胰岛素泵疗法的采用率正在上升。患者的舒适度和便利性正变得越来越重要，这促使人们开发出能最大限度减少疼痛、提供隐蔽性并简化胰岛素给药过程的设备。人们对糖尿病管理、胰岛素治疗以及胰岛素给药设备的益处的认识和教育不断提高，促进了这些设备被更广泛地接受和采用。政府的支持政策和报销制度促进了胰岛素治疗的普及，从而进一步刺激了市场的增长。人口老龄化，加上久坐不动的生活方式和不健康的饮食习惯等生活方式的改变，导致糖尿病发病率上升。人口结构的变化和生活方式的改变促使对胰岛素给药装置的需求不断增加。

报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构，评估全球竞争吸引力。此外，这些工具还对全球胰岛素给药装置市场的各个细分市场进行了全面评估。胰岛素给药装置行业的增长和趋势为本研究提供了一种全面的方法。

区域分析：

本部分涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲地区胰岛素给药装置市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。胰岛素给药设备市场的主要参与者包括 Becton, Dickinson and Company（美国）、Novo Nordisk A/S（丹麦）、Ypsomed Holding AG（瑞士）、Medtronic plo（爱尔兰）、Animas Corporation（美国）、Tandem Diabetes Care, Inc.(印度）。礼来公司（美国）和 Insulet 公司（美国）。本部分对竞争格局进行了整体分析，包括各种战略发展，如关键并购、未来产能、合作伙伴关系、财务概况、合作、新产品开发、新产品上市及其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可根据您的需求提供定制报告。

目 录

第 1 章：前言

  • 报告说明
    • 目标
    • 目标受众
    • 独特销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场调研过程
    • 市场调研方法

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：胰岛素给药装置 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场制约因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格趋势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章：全球胰岛素给药装置市场分析：按类型划分

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 笔（可重复使用笔、一次性笔）
  • 泵（外置/系带泵、贴片泵）
  • 笔针（标准笔针、Salety 笔针）
  • 注射器
  • 其他设备

第 6 章：全球胰岛素给药装置市场分析：按最终用户分类

  • 终端用户概述
  • 历史和预测数据
  • 按最终用户分析
  • 患者/家庭护理
  • 医院和诊所

第 7 章 ：全球胰岛素给药装置市场分析：按地区划分

  • 地区展望
  • 简介
  • 北美销售分析
    • 概述、历史和预测数据 销售分析
    • 北美地区销售分析
    • 北美地区各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据 销售分析
    • 欧洲分部销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据 销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据 销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据 销售分析
    • 中东和非洲各地区销售分析
    • 中东和非洲各国销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第8章 : 胰岛素给药装置企业的竞争格局

  • 胰岛素给药装置市场竞争
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品上市
  • 其他发展

第九章 : 公司概况

  • 顶级公司市场份额分析
  • 市场集中率
  • Becton
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Dickinson and Company (U.S.)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Novo Nordisk A/S (Denmark)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Ypsomed Holding AG (Switzerland)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Medtronic plo (Ireland)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Animas Corporation (U.S.)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Tandem Diabetes Care Inc. (U.S.)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Sanofi (France)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Biocon Ltd. (India).
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Eli Lilly and Company (U.S.)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Insulet Corporation (U.S.)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

注：在公司概况中，财务细节和近期发展视情况而定，私营公司可能不包括在内。

Product Code: VMR112111556

The global demand for Insulin Delivery Devices Market is presumed to reach the market size of nearly USD 44.73 BN by 2030 from USD 20.12 BN in 2022 with a CAGR of 10.5% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Thousand Units in 2022 and forecast to touch XX Thousand Units by 2030 with a CAGR of XX% during 2023-2030.

Insulin delivery devices are employed for the purpose of administering insulin to individuals diagnosed with diabetes. Insulin, a hormone, is produced by the pancreas that regulates blood sugar levels. In people with diabetes, the body either does not produce enough insulin (Type 1 diabetes) or does not effectively use the insulin produced (Type 2 diabetes). Insulin therapy is essential for managing diabetes and maintaining optimal blood glucose control.

MARKET DYNAMICS:

The increasing prevalence of diabetes worldwide is a key driver, as more individuals are diagnosed with diabetes and require insulin therapy. Innovative insulin delivery devices with features like accurate dosing, improved usability, connectivity, and data tracking capabilities have enhanced convenience and treatment outcomes. The adoption of insulin pump therapy is on the rise, thanks to improved pump designs, ease of use, and better reimbursement policies. Patient comfort and convenience are becoming increasingly important, leading to the development of devices that minimize pain, offer discreetness, and simplify insulin administration processes. Awareness and education about diabetes management, insulin therapy, and the benefits of insulin delivery devices have increased, contributing to their wider acceptance and adoption. Supportive government policies and reimbursement systems further stimulate market growth by promoting access to insulin therapy. The ageing population, coupled with lifestyle changes such as sedentary lifestyles and unhealthy eating habits, has resulted in a higher prevalence of diabetes. This demographic shift and lifestyle factors contribute to the increasing demand for insulin delivery devices.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of insulin delivery devices. The growth and trends of Insulin Delivery Devices Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the insulin delivery devices market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Pers (Reusable Pens, Disposable Pens)
  • Pumps (External/ Tethered Pumps, Patch Pumps)
  • Pen Needles (Standard Pen Needles, Salety Pen Needles)
  • Syringes
  • Other Devices

By End User

  • Patients/Homecare
  • Hospitals & Clinics

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Insulin Delivery Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the insulin delivery devices market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plo (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India). Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . INSULIN DELIVERY DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL INSULIN DELIVERY DEVICES MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Pers (Reusable Pens, Disposable Pens) Historic and Forecast Sales by Regions
  • 5.5 Pumps (External/ Tethered Pumps, Patch Pumps) Historic and Forecast Sales by Regions
  • 5.6 Pen Needles (Standard Pen Needles, Salety Pen Needles) Historic and Forecast Sales by Regions
  • 5.7 Syringes Historic and Forecast Sales by Regions
  • 5.8 Other Devices Historic and Forecast Sales by Regions

6 . GLOBAL INSULIN DELIVERY DEVICES MARKET ANALYSIS BY END USER

  • 6.1 Overview by End User
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End User
  • 6.4 Patients/Homecare Historic and Forecast Sales by Regions
  • 6.5 Hospitals & Clinics Historic and Forecast Sales by Regions

7 . GLOBAL INSULIN DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE INSULIN DELIVERY DEVICES COMPANIES

  • 8.1. Insulin Delivery Devices Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF INSULIN DELIVERY DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Becton
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Dickinson and Company (U.S.)
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Novo Nordisk A/S (Denmark)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Ypsomed Holding AG (Switzerland)
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Medtronic plo (Ireland)
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Animas Corporation (U.S.)
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Tandem Diabetes Care Inc. (U.S.)
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Sanofi (France)
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Biocon Ltd. (India).
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Eli Lilly and Company (U.S.)
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Insulet Corporation (U.S.)
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (Thousand Units and USD MN)
  • Pers (Reusable Pens, Disposable Pens) Market Sales by Geography (Thousand Units and USD MN)
  • Pumps (External/ Tethered Pumps, Patch Pumps) Market Sales by Geography (Thousand Units and USD MN)
  • Pen Needles (Standard Pen Needles, Salety Pen Needles) Market Sales by Geography (Thousand Units and USD MN)
  • Syringes Market Sales by Geography (Thousand Units and USD MN)
  • Other Devices Market Sales by Geography (Thousand Units and USD MN)
  • Analysis Market by End User (Thousand Units and USD MN)
  • Patients/Homecare Market Sales by Geography (Thousand Units and USD MN)
  • Hospitals & Clinics Market Sales by Geography (Thousand Units and USD MN)
  • Global Insulin Delivery Devices Market Sales by Geography (Thousand Units and USD MN)
  • North America Market Analysis (Thousand Units and USD MN)
  • United State Market Analysis (Thousand Units and USD MN)
  • Canada Market Analysis (Thousand Units and USD MN)
  • Mexico Market Analysis (Thousand Units and USD MN)
  • Europe Market Analysis (Thousand Units and USD MN)
  • Europe Market Estimate by Country (Thousand Units and USD MN)
  • United Kingdom Market Analysis (Thousand Units and USD MN)
  • France Market Analysis (Thousand Units and USD MN)
  • Germany Market Analysis (Thousand Units and USD MN)
  • Italy Market Analysis (Thousand Units and USD MN)
  • Russia Market Analysis (Thousand Units and USD MN)
  • Spain Market Analysis (Thousand Units and USD MN)
  • Rest of Europe Market Analysis (Thousand Units and USD MN)
  • Asia Pacific Market Analysis (Thousand Units and USD MN)
  • China Market Analysis (Thousand Units and USD MN)
  • Japan Market Analysis (Thousand Units and USD MN)
  • India Market Analysis (Thousand Units and USD MN)
  • South Korea Market Analysis (Thousand Units and USD MN)
  • Australia Market Analysis (Thousand Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Thousand Units and USD MN)
  • Latin America Market Analysis (Thousand Units and USD MN)
  • Brazil Market Analysis (Thousand Units and USD MN)
  • Argentina Market Analysis (Thousand Units and USD MN)
  • Peru Market Analysis (Thousand Units and USD MN)
  • Chile Market Analysis (Thousand Units and USD MN)
  • Rest of Latin America Market Analysis (Thousand Units and USD MN)
  • Middle East & Africa Market Analysis (Thousand Units and USD MN)
  • Saudi Arabia Market Analysis (Thousand Units and USD MN)
  • UAE Market Analysis (Thousand Units and USD MN)
  • Israel Market Analysis (Thousand Units and USD MN)
  • South Africa Market Analysis (Thousand Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Thousand Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Insulin Delivery Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Insulin Delivery Devices Market Size, by Region (Thousand Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (Thousand Units and USD MN)
  • Pers (Reusable Pens, Disposable Pens) Market Sales by Geography (Thousand Units and USD MN)
  • Pumps (External/ Tethered Pumps, Patch Pumps) Market Sales by Geography (Thousand Units and USD MN)
  • Pen Needles (Standard Pen Needles, Salety Pen Needles) Market Sales by Geography (Thousand Units and USD MN)
  • Syringes Market Sales by Geography (Thousand Units and USD MN)
  • Other Devices Market Sales by Geography (Thousand Units and USD MN)
  • Global Market Analysis by End User (Thousand Units and USD MN)
  • Patients/Homecare Market Sales by Geography (Thousand Units and USD MN)
  • Hospitals & Clinics Market Sales by Geography (Thousand Units and USD MN)
  • Global Market Sales (Thousand Units and USD MN)
  • North America Market Sales (Thousand Units and USD MN)
  • Europe Market Sales (Thousand Units and USD MN)
  • Asia Pacific Market Sales (Thousand Units and USD MN)
  • Latin America Market Sales (Thousand Units and USD MN)
  • Middle East & Africa Market Sales (Thousand Units and USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.